文献速递肿瘤 PET/CT

18F-FDG与18F-FLT-PET/CT纹理分析预测结直肠癌术后肿瘤复发的初步研究

A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-08-03

这项回顾性研究纳入32例术前接受18F-FDG和18F-FLT-PET/CT的结直肠癌患者,评估肿瘤异质性参数能否预测术后预后。中位随访55.9个月,8例进展;高分期、高18F-FDG-IV、高18F-FDG-SZV和高18F-FLT-熵显著预测较差5年PFS,其中18F-FDG-IV和SZV在校正分期和18F-FLT-熵后仍显著。

要点

  • 高18F-FDG-IV、高18F-FDG-SZV和高18F-FLT-熵与较差5年PFS显著相关。
  • 18F-FDG-IV和SZV在校正分期及18F-FLT-熵后仍为显著预后因素。
  • 18F-FDG PET异质性参数较18F-FLT-PET/CT异质性参数可能更有用。

核心结论

  • 18F-FDG PET异质性参数IV和SZV有潜力作为预测手术切除结直肠癌患者PFS的强预后因素,且比18F-FLT-PET/CT异质性参数更有用。

研究设计与样本

  • 回顾性研究,纳入32例接受手术的结直肠癌患者,术前均行18F-FDG和18F-FLT-PET/CT检查。

主要发现

  • 随访期间8例最终出现进展,24例存活无进展,平均随访PFS为55.9个月(范围1-72)。
  • 高分期(p=0.004)、高18F-FDG-IV(p=0.015)、高18F-FDG-SZV(p=0.013)和高18F-FLT-熵(p=0.015)显著预测较差5年PFS,其他参数未预测疾病结局。
  • 双变量分析中,18F-FDG-IV校正分期后p=0.004、校正18F-FLT-熵后p=0.007;18F-FDG-SZV校正分期后p=0.028、校正18F-FLT-熵后p=0.040,均仍显著。

关键数值与推荐

  • 代谢肿瘤体积定义为SUV≥2.5。
  • 纹理异质性参数包括变异系数、局部参数(熵、均匀性、不相似性)和区域参数(强度变异性IV、大小区域变异性SZV、区域百分比ZP)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This retrospective study was done to examine whether the heterogeneity in primary tumor F-18-fluorodeoxyglucose (18F-FDG) and 18F-3'-fluoro-3'-deoxythymidine (18F-FLT) distribution can predict prognosis of patients with colorectal cancer who received surgery. METHODS: The enrolled 32 patients with colorectal cancer underwent both 18F-FDG- and 18F-FLT-PET/CT studies before surgery. Clinicopathological factors, stage, SUVmax, SUVmean, metabolic tumor volume (SUV ≥ 2.5), total lesion glycolysis, total lesion proliferation and seven texture heterogeneity parameters (coefficient of variation, local parameters: entropy, homogeneity, and dissimilarity; and regional parameters: intensity variability [IV], size-zone variability [SZV], and zone percentage [ZP]) were obtained. Progression free survival (PFS) was calculated by the Kaplan-Meier method. Prognostic significance was assessed by Cox proportional hazards analysis. RESULTS: Eight patients had eventually come to progression, and 24 patients were alive without progression during clinical follow-up [mean follow-up PFS; 55.9 months (range, 1-72)]. High stage (p = 0.004), high 18F-FDG-IV (p = 0.015), high 18F-FDG-SZV (p = 0.013) and high 18F-FLT-entropy (p = 0.015) were significant in predicting poor 5-year PFS. Other parameters did not predict the disease outcome. At bivariate analysis, disease event hazards ratios for 18F-FDG-IV and 18F-FDG-SZV remained significant when adjusted for stage and 18F-FLT-entropy (18F-FDG-IV; p = 0.004 [adjusted for stage], 0.007 [adjusted for 18F-FLT-entropy]; 18F-FDG-SZV; p = 0.028 [adjusted for stage], 0.040 [adjusted for 18F-FLT-entropy]). CONCLUSION: 18F-FDG PET heterogeneity parameters, IV and SZV, have a potential to be strong prognostic factors to predict PFS of patients with surgically resected colorectal cancer and are more useful than 18F-FLT-PET/CT heterogeneity parameters.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Nakajo M, Kajiya Y, Tani A, et al. A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery. Eur J Nucl Med Mol Imaging. 2017. PMID: 28770274. doi:10.1007/s00259-017-3787-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。